Related Experiment Video

Updated: Jun 10, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Time to treatment and acute coronary syndromes: bridging the gap in rapid decision making

W Frank Peacock1

  • 1Department of Emergency Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.

Reviews in Cardiovascular Medicine
|August 12, 2010
PubMed

Insights

Cardiac troponin (Tn) aids diagnosis in suspected acute coronary syndromes (ACS). Early B-type natriuretic peptide (BNP) measurement may offer additional prognostic value alongside Tn and ECG for high-risk patients.

Area of Science:

  • Cardiology
  • Biomarker Research

Background:

  • Cardiac biomarkers are crucial for diagnosing and managing acute coronary syndromes (ACS).
  • Troponin (Tn) measurement is established for prognostic information in suspected ACS.
  • The incremental value of early B-type natriuretic peptide (BNP) measurement is less clear.

Purpose of the Study:

  • To evaluate the additional prognostic information provided by early B-type natriuretic peptide (BNP) measurement.
  • To determine if BNP offers incremental value beyond electrocardiography (ECG) and troponin (Tn) in suspected ACS.
  • To identify high-risk patients for timely intervention.

Main Methods:

  • Measurement of troponin (Tn) and B-type natriuretic peptide (BNP) levels.
  • Assessment of prognostic information in patients with chest pain and suspected ACS.
  • Comparison of biomarker data with ECG findings.

Main Results:

  • Troponin (Tn) measurement provides independent prognostic information in suspected ACS.
  • The incremental prognostic value of early B-type natriuretic peptide (BNP) measurement requires further establishment.
  • Combined Tn and BNP levels can aid in identifying high-risk patients.

Conclusions:

  • Early measurement of cardiac biomarkers like troponin (Tn) and B-type natriuretic peptide (BNP) is valuable.
  • Identifying high-risk patients through Tn and BNP levels facilitates timely treatment decisions.
  • Further research is needed to fully establish the incremental prognostic role of BNP in ACS.

More Related Videos

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide09:52

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide

Published on: January 15, 2017

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...